Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of cabotegravir and rilpivirine from dried blood spots
Ethel D. Weld(Johns Hopkins University), Mark A. Marzinke(Family Health International 360), Raphael J. Landovitz(APLA Health), Ryann Gollings(Johns Hopkins University), Teresa L. Parsons(Johns Hopkins University), Marybeth McCauley(Family Health International 360), Beatriz Grinsztejn(Fundação Oswaldo Cruz)
Cited by 10
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
|New England Journal of Medicine|2016|768